ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo

Journal of Neuroscience

Volumn 29, Issue 48, 2009, Pages 15317-15322

  Dumanis, Sonya B ^a   Tesoriero, Joseph A ^a   Babus, Lenard W ^a   Nguyen, Madeline T ^a   Trotter, Justin H ^b   Ladu, Mary Jo ^c   Weeber, Edwin J ^b   Turner, R Scott ^a   Xu, Baoji ^a   Rebeck, G William ^a   Hoe, Hyang Sook ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ARTICLE; BONE DENSITY; BRAIN CELL; BRAIN FUNCTION; BRAIN NERVE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; GENOTYPE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CELLS, CULTURED; CEREBRAL CORTEX; DENDRITES; DENDRITIC SPINES; EMBRYO, MAMMALIAN; HIPPOCAMPUS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; SILVER STAINING;

EID: 72849145019     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4026-09.2009     Document Type: Article

References (29)

1. Alpár A, Ueberham U, Brückner MK, Seeger G, Arendt T, Gärtner U (2006) Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice. Brain Res 1099:189-198.
2. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 270:27063-27071.
3. Brodbeck J, Balestra ME, Saunders AM, Roses AD, Mahley RW, Huang Y (2008) Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc Natl Acad Sci U S A 105:1343-1346.
4. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW (1999) Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci 19:4867-4880.
5. Daniele A, Matera MG, Seripa D, Acciarri A, Bizzarro A, Pilotto A, Masullo C (2009) APOE ε2/ε4 genotype a risk factor for primary progressive aphasia in women. Arch Neurol 66:910-912.
6. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27: 457-464.
7. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A 106:7209-7214.
8. Henze DA, Cameron WE, Barrionuevo G (1996) Dendritic morphology and its effects on the amplitude and rise-time of synaptic signals in hippocampal CA3 pyramidal cells. J Comp Neurol 369:331-344.
9. Herz J, Beffert U (2000) Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nat Rev Neurosci 1:51-58.
10. Hoe HS, Lee KJ, Carney RS, Lee J, Markova A, Lee JY, Howell BW, Hyman BT, Pak DT, Bu G, Rebeck GW (2009) Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci 29:7459-7473.
11. Ji Y, Gong Y, Gan W, Beach T, Holtzman DM, Wisniewski T (2003) Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122:305-315. (Pubitemid 37410162)
12. Korwek KM, Trotter JH, LaDu MJ, Sullivan PM, Weeber EJ (2009) ApoE isoform-dependent changes in hippocampal synaptic function. Mol Neurodegener 4:21.
13. Lanz TA, Carter DB, Merchant KM (2003) Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis 13:246-253.
14. Mauch DH, Nägler K, Schumacher S, Göritz C, Müller EC, Otto A, Pfrieger FW (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354-1357. (Pubitemid 33063104)
15. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852. (Pubitemid 24193454)
16. Pak DT, Yang S, Rudolph-Correia S, Kim E, Sheng M (2001) Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron 31:289-303. (Pubitemid 32762981)
17. Plassman BL, Welsh-Bohmer KA, Bigler ED, Johnson SC, Anderson CV, Helms MJ, Saunders AM, Breitner JC (1997) Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology 48:985-989. (Pubitemid 27175626)
18. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699.
19. Qiu S, Korwek KM, Weeber EJ (2006) A fresh look at an ancient receptor family: emerging roles for low density lipoprotein receptors in synaptic plasticity and memory formation. Neurobiol Learn Mem 85:16-29. (Pubitemid 41786046)
20. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11:575-580. (Pubitemid 23321768)
21. Riddell DR, Zhou H, Atchison K, Warwick HK, Atkinson PJ, Jefferson J, Xu L, Aschmies S, Kirksey Y, Hu Y, Wagner E, Parratt A, Xu J, Li Z, Zaleska MM, Jacobsen JS, Pangalos MN, Reinhart PH (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28:11445-11453.
22. Scarmeas N, Habeck CG, Hilton J, Anderson KE, Flynn J, Park A, Stern Y (2005) APOE related alterations in cerebral activation even at college age. J Neurol Neurosurg Psychiatry 76:1440-1444. (Pubitemid 41360988)
23. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977-1981. (Pubitemid 23069980)
24. Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272: 17972-17980. (Pubitemid 27306374)
25. Sullivan PM, Han B, Liu F, Mace BE, Ervin JF, Wu S, Koger D, Paul S, Bales KR (2009) Reduced levels of human apoE4 protein in an animal model of cognitive impairment. Neurobiol Aging. Advance online publication. Retrieved November 18, 2009. doi:10.1016/j.neurobiolaging.2009.05.011.
26. Teasdale GM, Nicoll JA, Murray G, Fiddes M (1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350:1069-1071. (Pubitemid 27437858)
27. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM (1999) Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J Neurochem 73:2613-2616.
28. Wang C, Wilson WA, Moore SD, Mace BE, Maeda N, Schmechel DE, Sullivan PM (2005) Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiol Dis 18:390-398. (Pubitemid 40431123)
29. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, Shoji S, HamaguchiH (1994) Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 36:656-659. (Pubitemid 24979413)